Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1986 Sep;76(9):1105–1108. doi: 10.2105/ajph.76.9.1105

Financial cost as an obstacle to hypertension therapy.

N B Shulman, B Martinez, D Brogan, A A Carr, C G Miles
PMCID: PMC1646559  PMID: 3740334

Abstract

A home health interview, including blood pressure measurements, was conducted on 4,688 adults representing the noninstitutionalized population of Georgia. Subjects with diastolic blood pressure greater than or equal to 90 mm Hg or on antihypertensive medication were considered hypertensive. The prevalence of uncontrolled moderate or severe hypertension (diastolic greater than or equal to 105 mm Hg) was 1.9 per cent. With the exception of White women, all race-sex groups with uncontrolled moderate or severe hypertension reported substantially lower per capita income than their mild or controlled hypertensive counterparts. A larger percentage of the uncontrolled moderate to severe hypertensives on medication, as compared to their mild or controlled counterparts, reported economic barriers to pharmacologic and medical care on cost of medicines (36 per cent vs 22 per cent); refills (36 per cent vs 16 per cent); and office visits (26 per cent vs 16 per cent). Black women reported these barriers more than Whites. These findings suggest that costs of antihypertensive care may be an obstacle in blood pressure control for certain population subgroups.

Full text

PDF
1105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caldwell J. R., Cobb S., Dowling M. D., de Jongh D. The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment. J Chronic Dis. 1970 Feb;22(8):579–592. doi: 10.1016/0021-9681(70)90034-2. [DOI] [PubMed] [Google Scholar]
  2. Carr A. A., Crane A. C. Hypertension care cost. J Med Assoc Ga. 1975 May;64(5):123–126. [PubMed] [Google Scholar]
  3. Carr A. A. Hypertension-care. J Med Assoc Ga. 1974 May;63(5):173–176. [PubMed] [Google Scholar]
  4. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  5. James S. A., Wagner E. H., Strogatz D. S., Beresford S. A., Kleinbaum D. G., Williams C. A., Cutchin L. M., Ibrahim M. A. The Edgecombe County (NC) High Blood Pressure Control Program: II. Barriers to the use of medical care among hypertensives. Am J Public Health. 1984 May;74(5):468–472. doi: 10.2105/ajph.74.5.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Keeler E. B., Brook R. H., Goldberg G. A., Kamberg C. J., Newhouse J. P. How free care reduced hypertension in the health insurance experiment. JAMA. 1985 Oct 11;254(14):1926–1931. [PubMed] [Google Scholar]
  7. Smith W. M. Mild essential hypertension: benefit of treatment: discussion. Ann N Y Acad Sci. 1978 Mar 30;304:74–80. doi: 10.1111/j.1749-6632.1978.tb25573.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES